The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded Amgen USA Inc. a $74,669.20 firm fixed price delivery order contract to provide AFLURIA QUADRIVALENT 0.5ML single-dose, pre-filled quadrivalent syringes designated for persons 36 months and older packaged in boxes of 10 units. The syringes' National Drug Code is 33332-0321-01. Performance will occur in Summit, New Jersey over the period from April 9, 2021 through October 15, 2021 to...
This is a $91,950.00 firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine production. The contract is for the delivery of flu vaccine, with a performance period ending on February 27, 2019. This award is not associated with a set-aside program, and no subcontractors are mentioned. Seqirus USA Inc. is a foreign-owned,...
Sanofi Pasteur Inc. has been awarded a $279,288 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply FLUZONE trivalent high dose influenza vaccine for individuals aged 65 years and older packaged in boxes of 10 doses each. Performance will occur at Sanofi Pasteur's facility in Swiftwater, Pennsylvania with delivery required by October 31, 2024. This order is being placed under Sanofi Pasteur's...
This is a firm fixed price delivery order issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $157,253.41 order is for the supply of flu vaccines, with a completion date of October 15, 2022. Seqirus USA Inc. is the prime contractor and there is no set-aside used for this award. Seqirus has previously held influenza vaccine contracts with...
This is a $109,075.20 firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Glaxosmithkline, LLC for the FLULAVAL influenza vaccine. The contract has no set-aside designation and the period of performance ran from the award date of April 9, 2019 through October 31, 2019. Glaxosmithkline has provided a range of pharmaceutical goods and services to various federal agencies, including vaccines, antiviral medications, and COVID-19 treatments....
This is a firm fixed price delivery order contract awarded to Seqirus USA Inc., a global biotechnology company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of AFLURIA PRE-FILLED SINGLE DOSE SYRINGE-QUADRIVALENT influenza vaccines, with a potential value of $125,895.00. The contract does not have a set-aside designation. Seqirus USA Inc. has previously received contracts from various federal agencies, including the Department of...
This is a $94,350.00 firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA) to Seqirus USA Inc. for the supply of flu vaccines. The contract has an ultimate completion date of October 30, 2016 and was awarded on March 29, 2016. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government...
This is a firm-fixed-price delivery order contract awarded by the Veterans Integrated Service Network 5, a division of the Department of Veterans Affairs, to Seqirus USA Inc. through its Seqirus USA, Inc. division. The contract is for the delivery of 10-dose multi-dose vials of trivalent (adult dose) influenza vaccines, with a ceiling value of $81,770.00 and a performance period ending on March 1, 2017. The contract is not set aside and is part of Seqirus's broader portfolio of federal vaccine...
The Department of State Bureau of Administration awarded a delivery order contract to Sanofi Pasteur Inc. for the provision of FLUZONE QUADRUVALENT FLUE VACCINES. The $209,248.32 firm fixed price contract was awarded on July 10, 2017 with a completion date of February 26, 2019. The contract was not set aside and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical goods. The contract, valued at $85,005.00, is for the supply of FLUZONE influenza vaccines. The award was made without any set-aside designation and the performance location is Sanofi Pasteur's facility in Swiftwater, Pennsylvania. Sanofi Pasteur Inc. holds several Indefinite Delivery Vehicles (IDVs) with various...